Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchoscopic Cryoablation + Sintilimab + Chemo for NSCLC with Central Airway Obstruction
NCT06604351Phase 2Not yet recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- Sep 2024
- Primary completion
- Oct 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in non-small cell lung cancer (NSCLC), sponsored by Hunan Cancer Hospital. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
sintilimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06604351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06604351.